Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
242.77
-6.97 (-2.79%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$396.50
Upside
+63.32%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $320 → $270 | Hold | Maintains | $320 → $270 | +11.22% | Apr 17, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $360 → $345 | Hold | Maintains | $360 → $345 | +42.11% | Feb 12, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $481 | Buy | Reiterates | $481 | +98.13% | Jan 14, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $369 → $481 | Buy | Maintains | $369 → $481 | +98.13% | Dec 9, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $400 → $450 | Strong Buy | Maintains | $400 → $450 | +85.36% | Oct 31, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $446 → $469 | Buy | Maintains | $446 → $469 | +93.19% | Oct 31, 2024 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $350 → $400 | Hold → Strong Buy | Upgrades | $350 → $400 | +64.77% | Oct 1, 2024 |
| Wells Fargo | Wells Fargo | Hold Initiates $340 | Hold | Initiates | $340 | +40.05% | Aug 27, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $401 | Buy | Reiterates | $401 | +65.18% | Aug 16, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $402 → $401 | Buy | Maintains | $402 → $401 | +65.18% | Aug 2, 2024 |
| Citigroup | Citigroup | Hold Maintains $300 → $350 | Hold | Maintains | $300 → $350 | +44.17% | Aug 2, 2024 |
| UBS | UBS | Strong Buy Maintains $420 → $385 | Strong Buy | Maintains | $420 → $385 | +58.59% | May 8, 2024 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $400 → $365 | Strong Buy → Hold | Downgrades | $400 → $365 | +50.35% | Apr 3, 2024 |
| UBS | UBS | Strong Buy Maintains $395 → $420 | Strong Buy | Maintains | $395 → $420 | +73.00% | Feb 16, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $484 → $480 | Buy | Maintains | $484 → $480 | +97.72% | Feb 16, 2024 |
| UBS | UBS | Strong Buy Initiates $395 | Strong Buy | Initiates | $395 | +62.71% | Dec 7, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.